We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04091737
Recruitment Status : Terminated (Unanticipated delays, not for safety reasons)
First Posted : September 17, 2019
Last Update Posted : June 18, 2021
Sponsor:
Information provided by (Responsible Party):
CSL Behring

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 5, 2021
Actual Study Completion Date : May 5, 2021